Genesis Molecular AI

Genesis Molecular AI is a biotechnology company that pairs leading AI researchers and simulation experts with world-class drug hunters to optimize drug discovery and create new medicines. It develops AI research, an AI platform called GEMS, and drug discovery programs for its own pipeline and major pharma partners.

Genesis Molecular AI is a biotechnology company. It pairs leading AI researchers and simulation experts with world-class drug hunters to optimize drug discovery and create new medicines. The company is supported by world-leading AI and life science investors. In 2026, Incyte expanded its collaboration with Genesis, with Genesis receiving $120M upfront consideration and data for model training, and at least 5 additional targets.

• Incyte Partnership Expansion

  [2]About: AI Researchers & Drug Hunters | Genesis Molecular AIgenesis.ml

  Genesis receives $120M upfront consideration and data for model training. With strong results on initial programs, Incyte expanded the ongoing collaboration with at least 5 additional targets.

• GEMS

  The AI operating system for molecular design.

• Pearl

  The Next Generation Foundation Model for Drug Discovery.

1. 1Genesis Molecular AI | AI for Small Molecule Drug Discoverygenesis.ml
2. 2About: AI Researchers & Drug Hunters | Genesis Molecular AIgenesis.ml
3. 3Genesis Molecular AIwikidata.org